NurslixJournal
藥理與非經腸給藥 · MEDIUM · MCQ

一位病人正在接受哌拉西林-他唑巴坦 (piperacillin-tazobactam) 的連續輸注。哪個評估發現需要立即通知醫護人員?

A client is receiving a continuous infusion of piperacillin-tazobactam. Which assessment finding warrants immediate notification of the healthcare provider?

  • AMild diarrhea
    輕微腹瀉
  • BAbdominal pain
    腹痛
  • CRash✓ 正解
    皮疹
  • DFever
    發燒
Explanation · 中文詳解

哌拉西林-他唑巴坦 (Piperacillin-Tazobactam) 為青黴素類抗生素。皮疹 (Rash) 往往是過敏反應的早期表現,在青黴素類藥物中尤為常見。雖然多數皮疹為輕微,但為了預防病情惡化至嚴重過敏性休克或史帝文生-強森症候群 (SJS),護理師必須採取預防性措施,立即通知醫師評估是否繼續給藥。

Piperacillin-tazobactam is a penicillin-class antibiotic. A rash often represents an early manifestation of an allergic reaction and is especially common with penicillin derivatives. Although most rashes are mild, to prevent progression to severe anaphylactic shock or Stevens-Johnson syndrome (SJS), the nurse must take precautionary measures and immediately notify the physician to determine whether to continue the medication.

Related · 同分類的其他題目

More from Pharmacological & Parenteral

瀏覽全部 2,027 題 藥理與非經腸給藥 →
Jump to another chapter